Correlation Between Compagnie Plastic and Mereo BioPharma

Can any of the company-specific risk be diversified away by investing in both Compagnie Plastic and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compagnie Plastic and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Compagnie Plastic Omnium and Mereo BioPharma Group, you can compare the effects of market volatilities on Compagnie Plastic and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compagnie Plastic with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compagnie Plastic and Mereo BioPharma.

Diversification Opportunities for Compagnie Plastic and Mereo BioPharma

-0.25

Correlation Coefficient

Compagnie Plastic  Mereo BioPharma

Very good diversification

The 3 months correlation between Compagnie and Mereo is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Compagnie Plastic Omnium and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Compagnie Plastic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compagnie Plastic Omnium are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Compagnie Plastic i.e., Compagnie Plastic and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Compagnie Plastic and Mereo BioPharma

Assuming the 90 days trading horizon Compagnie Plastic Omnium is expected to generate 0.79 times more return on investment than Mereo BioPharma. However, Compagnie Plastic Omnium is 1.26 times less risky than Mereo BioPharma. It trades about 0.02 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.15 per unit of risk. If you would invest  985.00  in Compagnie Plastic Omnium on December 24, 2024 and sell it today you would earn a total of  17.00  from holding Compagnie Plastic Omnium or generate 1.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Compagnie Plastic Omnium  vs.  Mereo BioPharma Group

Compagnie Plastic Omnium

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Compagnie Plastic Omnium are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Compagnie Plastic is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Mereo BioPharma Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Compagnie Plastic and Mereo BioPharma

The main advantage of trading using opposite Compagnie Plastic and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compagnie Plastic position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.

The idea behind Compagnie Plastic Omnium and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.